NCT03724630 is a clinical trial in Simple Bone Cyst, sponsored by Assiut University.

Who is sponsoring NCT03724630?

NCT03724630 is sponsored by Assiut University.

What condition does NCT03724630 study?

NCT03724630 studies Simple Bone Cyst.

Is NCT03724630 still recruiting?

NCT03724630 is currently status unknown. Last updated 30 October 2018.

Last reviewed 2018-10-30 · How we verify

NCT03724630

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Results of Multiple Aspirations and Injections of Unicameral Bone Cyst by Methyl Prednisolone Acetate

Status unknown Last updated 30 October 2018

What this trial tests

trial in Simple Bone Cyst in 15 participants. Status unknown.

Timeline

1 January 2019

Primary endpoint
1 January 2020

1 March 2020

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	15
Start date	1 January 2019
Primary completion	1 January 2020
Estimated completion	1 March 2020

Conditions studied

Simple Bone Cyst — all drugs for Simple Bone Cyst →

Sponsor

Assiut University

Who can join

Under 18, any sex, with Simple Bone Cyst. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluation of the efficacy of methyl prednisolone injection in treatment o f simple bone cyst to prevent all possible complications as pathological fractures and to avoid prolonged restriction of physical activity

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03724630 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 30 October 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03724630.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing